Recombinant human ErbB3 fragment vaccine - ZensunAlternative Names: Recombinant human neu epitope peptide 12 - Zensun; rhErbB3-f - Zensun; Therapeutic Tumour Vaccine - Zensun
Latest Information Update: 15 Apr 2016
At a glance
- Originator Zensun (Shanghai) Sci & Tech
- Class Cancer vaccines
- Mechanism of Action ERBB 2 receptor antagonists; ERBB-3 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Cancer